Acurx Announces Ibezapolstat Scientific Posters And Presentations At ClostPath 2023 IDWeek 2023 Scientific Conferences
Portfolio Pulse from Benzinga Newsdesk
Acurx Pharmaceuticals has announced that it will present scientific posters and presentations on its drug, Ibezapolstat, at the ClostPath 2023 and IDWeek 2023 scientific conferences.
October 19, 2023 | 11:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acurx's announcement of presenting Ibezapolstat at scientific conferences could potentially increase investor interest and positively impact the company's stock.
Presentations at scientific conferences often lead to increased visibility and credibility for a company's products. This could potentially lead to increased investor interest in Acurx, and a positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100